Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 28% ± 10% | |
| natural killer cell | 4 studies | 20% ± 2% | |
| B cell | 4 studies | 18% ± 1% | |
| ciliated cell | 4 studies | 24% ± 5% | |
| CD8-positive, alpha-beta T cell | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 410.99 | 1445 / 1445 | 100% | 29.53 | 183 / 183 |
| ovary | 100% | 519.68 | 180 / 180 | 100% | 50.92 | 430 / 430 |
| uterus | 100% | 495.51 | 170 / 170 | 100% | 24.94 | 459 / 459 |
| thymus | 100% | 568.35 | 653 / 653 | 100% | 27.17 | 604 / 605 |
| stomach | 100% | 352.39 | 359 / 359 | 99% | 32.87 | 284 / 286 |
| intestine | 100% | 469.78 | 966 / 966 | 99% | 35.79 | 523 / 527 |
| prostate | 100% | 539.85 | 245 / 245 | 99% | 23.77 | 498 / 502 |
| bladder | 100% | 408.10 | 21 / 21 | 98% | 31.98 | 495 / 504 |
| skin | 100% | 386.59 | 1809 / 1809 | 98% | 22.32 | 463 / 472 |
| liver | 100% | 315.44 | 225 / 226 | 98% | 19.02 | 399 / 406 |
| lung | 100% | 430.00 | 577 / 578 | 98% | 22.33 | 1129 / 1155 |
| pancreas | 100% | 294.30 | 328 / 328 | 97% | 24.23 | 172 / 178 |
| kidney | 100% | 508.01 | 89 / 89 | 96% | 17.19 | 868 / 901 |
| breast | 100% | 461.54 | 459 / 459 | 96% | 20.33 | 1073 / 1118 |
| brain | 99% | 292.19 | 2610 / 2642 | 97% | 16.65 | 682 / 705 |
| adrenal gland | 100% | 642.48 | 258 / 258 | 91% | 17.47 | 209 / 230 |
| eye | 0% | 0 | 0 / 0 | 100% | 19.69 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 47.76 | 29 / 29 |
| spleen | 100% | 1151.63 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 17.82 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 63.16 | 1 / 1 |
| blood vessel | 100% | 382.10 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 370.01 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 454.24 | 920 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 218.92 | 845 / 861 | 0% | 0 | 0 / 0 |
| muscle | 83% | 123.40 | 665 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1903724 | Biological process | positive regulation of centriole elongation |
| GO_0045724 | Biological process | positive regulation of cilium assembly |
| GO_0048570 | Biological process | notochord morphogenesis |
| GO_0005814 | Cellular component | centriole |
| GO_0005813 | Cellular component | centrosome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004864 | Molecular function | protein phosphatase inhibitor activity |
| GO_0019902 | Molecular function | phosphatase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PPP1R35 |
| Protein name | Protein phosphatase 1 regulatory subunit 35 |
| Synonyms | C7orf47 |
| Description | FUNCTION: During centriole duplication, plays a role in the centriole elongation by promoting the recruitment of the microtubule-binding elongation machinery through its interaction with RTTN, leading to the centriole to centrosome conversion . In addition, may play a role in the primary cilia assembly (By similarity). . |
| Accessions | ENST00000292330.3 Q8TAP8 |
